Sandoz Group AG
SDZ
Clasificación en acciones
#579
Operating globally, Sandoz Group AG specializes in the development, production,... Operating globally, Sandoz Group AG specializes in the development, production, and distribution of generic medications and biosimilar products. The company's portfolio includes the creation and sale of finished dosage forms for small molecule pharmaceuticals, often supplied to other entities. Sandoz is also a significant player in the biotechnology sector, providing protein-based products such as biosimilars and offering specialized manufacturing services within this field. Furthermore, it supplies anti-infective products, including active pharmaceutical ingredients (APIs) and intermediates, with a strong emphasis on antibiotics. Established in 1886, Sandoz maintains its headquarters in Rotkreuz, Switzerland.
Precio por acción
$95.99
Capitalización bursátil
$41.53B
Cambio (1 día)
0.79%
Cambio (1 año)
58.61%
País
CH
Comercio Sandoz Group AG (SDZ)
Categoría
Healthcare
EPS de Sandoz Group AG (SDZ)
EPS a fecha de 2026 TTM: 0
Según los últimos informes financieros y el precio de las acciones de Sandoz Group AG, el EPS actual de la empresa (TTM) es 0. Al final del año 2026, la empresa tenía un EPS de 0 igual a al EPS de 2026, que fue de 0.
Historial de EPS de Sandoz Group AG desde 2020 hasta 2026
EPS al final de cada año
| Año | EPS | Cambiar |
|---|---|---|
| 2025 | $2.12 | 0.00% |
| 2024 | 0.00 | -100.00% |
| 2023 | $0.18 | -90.86% |
| 2022 | $1.97 | 2.60% |
| 2021 | $1.92 | 102.11% |
| 2020 | $0.95 | 0.00% |
EPS de empresas similares o competidoras
| Empresa | EPS | Diferencia de EPS | País |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $0.56 | - |
IN
|
